Abstract
Motor neuron disease (MND) is one of the 3 commonest adult onset neurodegenerative disorders with a life-time risk of approximately 1 in 400. Death in most patients results from neuromuscular respiratory failure. The heterogeneity and complexity of MND has posed a challenge for neuroprotective therapy development. This lecture will cover 4 areas of topical interest.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
